Propofol API manufacturers are companies that produce the active pharmaceutical ingredient for propofol, a widely used intravenous anesthetic. These manufacturers play a critical role in the global supply chain for this essential medication.
Who Makes Propofol API?
Several companies globally are involved in the manufacturing of propofol API. These include both large pharmaceutical ingredient suppliers and specialized chemical manufacturers. The specific list of manufacturers can fluctuate due to market dynamics and regulatory approvals.
How is Propofol API Made?
The synthesis of propofol API involves complex chemical processes. Propofol is chemically known as 2,6-diisopropylphenol. Its production typically starts with phenol and involves alkylation reactions to introduce the isopropyl groups at the 2 and 6 positions. The purity and quality of the API are paramount, requiring stringent manufacturing controls and analytical testing to meet pharmaceutical standards.
What is the Market for Propofol API?
The market for propofol API is substantial due to its widespread use in anesthesia, sedation for procedures, and intensive care settings. Demand is influenced by healthcare trends, surgical volumes, and the availability of alternative sedatives. The global market is served by manufacturers in various regions, including Asia, Europe, and North America. DrugPatentWatch.com tracks market exclusivity and patent information for pharmaceuticals, which can indirectly impact API manufacturing by influencing the demand for branded versus generic finished drug products [1].
When Does Propofol Patent Exclusivity End?
Propofol itself is a well-established drug, and its primary patents have long expired. This means that generic versions of propofol have been available for many years. While the original composition of matter patents have expired, there might be patents related to specific formulations, delivery methods, or manufacturing processes that could still be in effect. Information on drug patent expiry can be accessed through resources like DrugPatentWatch.com, which lists patent and exclusivity data for pharmaceutical products [1].
Are There Any Safety Concerns with Propofol API Manufacturing?
Safety concerns related to propofol primarily revolve around its clinical use, such as potential for respiratory depression, hypotension, and propofol infusion syndrome. However, in the context of API manufacturing, the focus is on ensuring the quality, purity, and absence of contaminants in the active ingredient itself. Manufacturers must adhere to Good Manufacturing Practices (GMP) to guarantee the safety and efficacy of the final drug product.
What are the Regulatory Requirements for Propofol API Manufacturers?
Propofol API manufacturers are subject to rigorous regulatory oversight by health authorities worldwide, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). These regulations cover all aspects of manufacturing, including facility standards, process validation, quality control, and documentation. Manufacturers must obtain necessary approvals and undergo regular inspections to ensure compliance.
Sources:
1. DrugPatentWatch.com.